These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 26817735)
1. Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials. Wong YW; Mentz RJ; Felker GM; Ezekowitz J; Pieper K; Heizer G; Hasselblad V; Metra M; O'Connor CM; Armstrong PW; Starling RC; Hernandez AF Eur J Heart Fail; 2016 Jun; 18(6):684-92. PubMed ID: 26817735 [TBL] [Abstract][Full Text] [Related]
2. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. Ezekowitz JA; Hernandez AF; O'Connor CM; Starling RC; Proulx G; Weiss MH; Bakal JA; Califf RM; McMurray JJ; Armstrong PW J Am Coll Cardiol; 2012 Apr; 59(16):1441-8. PubMed ID: 22497823 [TBL] [Abstract][Full Text] [Related]
3. Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF. Mentz RJ; Hernandez AF; Stebbins A; Ezekowitz JA; Felker GM; Heizer GM; Atar D; Teerlink JR; Califf RM; Massie BM; Hasselblad V; Starling RC; O'Connor CM; Ponikowski P Eur J Heart Fail; 2013 Apr; 15(4):456-64. PubMed ID: 23159547 [TBL] [Abstract][Full Text] [Related]
4. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). Greene SJ; Hernandez AF; Sun JL; Metra M; Butler J; Ambrosy AP; Ezekowitz JA; Starling RC; Teerlink JR; Schulte PJ; Voors AA; Armstrong PW; O'Connor CM; Mentz RJ Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623769 [TBL] [Abstract][Full Text] [Related]
5. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. Ambrosy AP; Cerbin LP; Armstrong PW; Butler J; Coles A; DeVore AD; Dunlap ME; Ezekowitz JA; Felker GM; Fudim M; Greene SJ; Hernandez AF; O'Connor CM; Schulte P; Starling RC; Teerlink JR; Voors AA; Mentz RJ JACC Heart Fail; 2017 Jan; 5(1):1-13. PubMed ID: 28034373 [TBL] [Abstract][Full Text] [Related]
6. Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF). Howlett JG; Ezekowitz JA; Podder M; Hernandez AF; Diaz R; Dickstein K; Dunlap ME; Corbalán R; Armstrong PW; Starling RC; O'Connor CM; Califf RM; Fonarow GC; Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):534-42. PubMed ID: 23899930 [TBL] [Abstract][Full Text] [Related]
7. Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial. Abualnaja S; Podder M; Hernandez AF; McMurray JJ; Starling RC; O'Connor CM; Califf RM; Armstrong PW; Ezekowitz JA J Am Heart Assoc; 2015 Aug; 4(8):e002092. PubMed ID: 26304935 [TBL] [Abstract][Full Text] [Related]
8. Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF). Ezekowitz JA; Podder M; Hernandez AF; Armstrong PW; Starling RC; O'Connor CM; Califf RM BMJ Open; 2016 Mar; 6(3):e010201. PubMed ID: 26988350 [TBL] [Abstract][Full Text] [Related]
9. Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial. Cerbin LP; Ambrosy AP; Greene SJ; Armstrong PW; Butler J; Coles A; DeVore AD; Ezekowitz JA; Hernandez AF; Metra M; Starling RC; Tang W; Teerlink JR; Voors AA; Wu A; O'Connor CM; Mentz RJ JACC Heart Fail; 2018 Apr; 6(4):298-307. PubMed ID: 29525328 [TBL] [Abstract][Full Text] [Related]
16. Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF. Patel PA; Heizer G; O'Connor CM; Schulte PJ; Dickstein K; Ezekowitz JA; Armstrong PW; Hasselblad V; Mills RM; McMurray JJ; Starling RC; Tang WH; Califf RM; Hernandez AF Circ Heart Fail; 2014 Nov; 7(6):918-25. PubMed ID: 25281655 [TBL] [Abstract][Full Text] [Related]
17. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure). Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790 [TBL] [Abstract][Full Text] [Related]
18. Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF. Greene SJ; DeVore AD; Sheng S; Fonarow GC; Butler J; Califf RM; Hernandez AF; Matsouaka RA; Samman Tahhan A; Thomas KL; Vaduganathan M; Yancy CW; Peterson ED; O'Connor CM; Mentz RJ JACC Heart Fail; 2019 Nov; 7(11):980-992. PubMed ID: 31606362 [TBL] [Abstract][Full Text] [Related]
19. Nesiritide in acute decompensated heart failure: a pooled analysis of randomized controlled trials. Abraham WT; Trupp RJ; Jarjoura D Clin Cardiol; 2010 Aug; 33(8):484-9. PubMed ID: 20734445 [TBL] [Abstract][Full Text] [Related]
20. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M; Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]